No More Needles: Insulin Pill Successful in Test

Wednesday, 20 Mar 2013 12:17 PM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink
Novo Nordisk's oral insulin successfully completed an early-stage study, according to the Danish drugmaker’s partner, Merrion Pharmaceuticals Plc.,  bringing what would be the first product of its kind a step closer to market.
 
The goals of the clinical trial, the first of three phases of human testing usually required by regulators for marketing approval, were to test the insulin tablet’s safety, tolerability, exposure and effect on blood-sugar levels, Dublin-based Merrion said today in a statement.

Special: These 5 Things Flush 40 lbs. of Fat Out of Your Body.
 
Insulin, a hormone used by the body to convert blood sugar into energy, is currently only available as an injection for diabetics whose bodies either don’t produce enough insulin or have become resistant to it.

Merrion’s Gipet technology was used in the formulation of Novo’s oral insulin, known as NN1954. Merrion will receive payments when the product meets certain goals during development under a 2008 agreement between the companies.
 
Eighty-three people were enrolled in the trial, which began in May and ended in October, according to an entry on the U.S. government website clinicaltrials.gov.
 
 

© Copyright 2014 Bloomberg News. All rights reserved.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink

 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Find Your Condition
Follow Newsmax

You May Also Like

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved
> >